Antidepressants and hypothalamic-pituitary-adrenocortical regulation.
about
Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study.Biomarkers predicting antidepressant treatment response: how can we advance the field?The organisation of the stress response, and its relevance to chiropractors: a commentaryInvited review: the evolution of antidepressant mechanismsHippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposureLithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patientsDexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoterMad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsThe GABAergic deficit hypothesis of major depressive disorder.Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.The CRF system mediates increased passive stress-coping behavior following the loss of a bonded partner in a monogamous rodent.gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety.Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapiesThe Effects of Venlafaxine and Dexamethasone on the Expression of HSP70 in Rat C6 Glioma CellsOpen questions in current models of antidepressant action.Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposityHypocortisolism as a potential marker of allostatic load in children: associations with family risk and internalizing disorders.The diagnosis of depression: current and emerging methods.Androgen regulation of corticotropin-releasing hormone receptor 2 (CRHR2) mRNA expression and receptor binding in the rat brain.Depression, antidepressants, and the shrinking hippocampusEvolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in ratsDendritic morphology of hippocampal and amygdalar neurons in adolescent mice is resilient to genetic differences in stress reactivity.Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.No associations between single nucleotide polymorphisms in corticoid receptor genes and heart rate and cortisol responses to a standardized social stress test in adolescents: the TRAILS study.Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.Chronic clomipramine treatment reverses core symptom of depression in subordinate tree shrewsTotal flavonoids extracted from xiaobuxin-tang on the hyperactivity of hypothalamic-pituitary-adrenal axis in chronically stressed ratsReduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1.Pathophysiology of depression and mechanisms of treatmentGenetics of stress response and stress-related disorders.Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress[Depression and stress: is there an endophenotype?]Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depressionA role for corticotropin-releasing factor in functional gastrointestinal disorders.Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene influences fMRI signal responses during emotional stimulus processing.Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats.Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.
P2860
Q25256599-9FE7CF61-A57A-4301-BAE7-6623208C6489Q27026147-A83C5167-531A-454A-A86F-753DBFED7D20Q27498871-90A6ED5B-867F-48BA-8D81-B847A8BF4097Q28241221-86BAF173-0356-4008-A39D-BD874E27201CQ28346146-DD32C808-FD49-4CE5-8006-73C89D95BB00Q28478124-4D5A00AC-BB31-4109-8E3C-E6681A55F740Q28576128-314B86B9-CCC3-45E8-AAC1-FB4898855739Q30364736-B52D8A7D-D2DF-4078-8A3E-6A0ADF42809AQ30464954-83714EB8-754F-417A-89AA-D9F9AF0EE586Q30467322-C1DD3974-ECCE-40E1-9A87-2879960A1412Q30487068-70027A0B-F284-43D9-9933-4D7DC636037EQ30496339-33ECB5CF-8663-4ECA-805F-7AC2E50E5C3BQ30862113-EF6C5DDF-EAB1-4721-A1F8-0C1DF5E6123AQ33624771-9C80A6A5-7910-4165-84A8-BAA6FC2B0CECQ33766555-613BF30F-71BA-4D4F-8095-1692433B241FQ33767182-CE3259A2-A811-431A-B9E1-61EB5995EDE5Q33770354-E1FA153A-F242-4D45-8755-CF8A76926A94Q33810895-E2E3BEEE-D1B3-40B5-9C6A-ECB8504DF0D0Q33887233-E36D6F5C-BD88-477D-AC3B-9C6016CAC9CAQ33937681-6D3DA799-88FE-4E3C-A9E6-1F8CF5C368A2Q33947617-B11A06CF-E0E7-4A61-B7C2-60DE4A55C6D8Q33980290-50B783F1-C545-48DA-B7A2-A1F6B665749BQ34226624-5F2F17BB-0570-4EE9-9891-DCA5F87CCEACQ34305851-1239EEC8-2E5B-4D39-B7E3-605C54B9A538Q34390088-C0C156F7-0B5D-464B-A9C4-587C25131885Q34514099-EB39D206-EEAF-41E5-B2F9-A06B056AC0F9Q34605416-0DDF6AD0-4DC6-4C0F-9292-4CA635E30550Q34806426-570C5B70-7C28-49E3-8698-08C99C50338BQ35061145-CCA9DF63-AF2D-4F5F-A561-40AF66655D28Q35105475-726490F2-1EAE-42DE-B44D-200EF9CE16A6Q35126905-ACEE0E3E-54C2-4735-B0E5-B1B3CDB89E30Q35236438-55EA125B-493B-44D6-9FBD-B02C877AF16AQ35236890-A77FAA3E-5ADB-4978-89CF-1CEB825E07A8Q35546525-D9749C3C-F1B3-4171-AE3B-DB0AD1633AB1Q35743450-568F2D66-501B-4853-9833-9696F8D3CCB7Q35790395-37630BEA-ADE1-4DA9-87DF-670A03F5EDC7Q35809350-D19EEF30-F7A3-4698-861E-112E7A84A044Q35816431-A039307D-39E0-4210-99C4-189FE15943BAQ35837748-5158EDE1-C9E4-4110-ACEC-707D1E7675F7Q35844396-0703CC94-63DD-43C3-8AFE-A7F7DBD2FDA3
P2860
Antidepressants and hypothalamic-pituitary-adrenocortical regulation.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Antidepressants and hypothalamic-pituitary-adrenocortical regulation.
@en
type
label
Antidepressants and hypothalamic-pituitary-adrenocortical regulation.
@en
prefLabel
Antidepressants and hypothalamic-pituitary-adrenocortical regulation.
@en
P356
P1433
P1476
Antidepressants and hypothalamic-pituitary-adrenocortical regulation.
@en
P2093
P304
P356
10.1210/ER.17.2.187
P577
1996-04-01T00:00:00Z